NCT07447271

Brief Summary

This study retrospectively analyzed medical records and imaging records (ultrasound images, fluoroscopy-guided images) of US-CSNRB and FL-CTFEB procedures performed at the Yangsan Pusan National University Hospital Pain Clinic outpatient department from May 1, 2019, to April 30, 2024. It compared the therapeutic effects (pain reduction), procedure-related indicators (comparison of contrast agent spread), safety (incidence of complications), and changes in analgesic usage. The primary outcome of this study is the difference in pain chage (Visual Analogue Scale, VAS) between patients undergoing US-CSNRB and FL-CTFEB. The secondary outcomes are comparison of contrast agent spread and comparison of procedure-related complication rates.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
330

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Dec 2025

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 22, 2025

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

February 21, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

March 3, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 4, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 4, 2026

Completed
Last Updated

March 3, 2026

Status Verified

February 1, 2026

Enrollment Period

4 months

First QC Date

February 21, 2026

Last Update Submit

February 27, 2026

Conditions

Keywords

ultrasoundfluoroscopynerve blockcervical radiculopathy

Outcome Measures

Primary Outcomes (1)

  • The difference in pain change

    the difference in pain change, assessed using the visual analogue scale (VAS), between patients who underwent US-CSNRB and those who underwent FL-CTFEB

    baseline, 1 month, 2 month, 3 month

Secondary Outcomes (2)

  • The pattern of contrast spread

    periprocedural

  • The incidence of procedure-related complications

    Periprocedural

Study Arms (2)

group U

EXPERIMENTAL
Procedure: ultrasound guided cervical selective nerve root block

group F

ACTIVE COMPARATOR
Procedure: fluoroscopy-guided cervical transforaminal epidural block

Interventions

A patient presenting to the pain clinic with cervical neck pain and upper extremity radicular pain, whose symptoms did not improve with medication, demonstrated a positive Spurling test on physical examination, and showed cervical radiculopathy at the C3/4 to C7/T1 level on imaging studies (CT or MRI), underwent an ultrasound-guided cervical selective nerve root block

Also known as: fluoroscopic guided cervical transforaminal epidural block
group U

A patient presenting to the pain clinic with cervical neck pain and upper extremity radicular pain, whose symptoms did not improve with medication, demonstrated a positive Spurling test on physical examination, and showed cervical radiculopathy at the C3/4 to C7/T1 level on imaging studies (CT or MRI), underwent a fluoroscopy-guided cervical transforaminal epidural block

group F

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult male and female patients aged 18 years or older.
  • Patients diagnosed with cervical radiculopathy who underwent US-guided or FL-guided procedures.
  • Patients with clearly documented pain scale (VAS) assessments in medical records at the following time points: 1st visit (before the procedure), 2nd visit, 3rd visit, and at least 3 months post-procedure.
  • Patients who underwent procedures for lesions in a single or adjacent two segments.

You may not qualify if:

  • Patients who underwent surgical treatment within one month after the procedure due to progressive neurological deficits.
  • Patients with severe systemic diseases (e.g., cancer, severe immunosuppressive disorders) that may affect pain assessment.
  • Patients with severe systemic diseases (e.g., cancer, severe immunosuppressive disorders) that may affect pain assessment.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Pusan National University Yangsan Hospital

Yangsan, Gyeongsangnam-do, 50612, South Korea

Location

MeSH Terms

Conditions

Radiculopathy

Condition Hierarchy (Ancestors)

Peripheral Nervous System DiseasesNeuromuscular DiseasesNervous System Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Professor

Study Record Dates

First Submitted

February 21, 2026

First Posted

March 3, 2026

Study Start

December 22, 2025

Primary Completion

May 4, 2026

Study Completion

May 4, 2026

Last Updated

March 3, 2026

Record last verified: 2026-02

Locations